Introduction The relationship between the intestinal microbiota dysbiosis, inflammation, and
cardiovascular disorders (CVDs) has become evident, based on a growing body of literature …

Atherosclerosis is a major cause of mortalities and morbidities worldwide. It is associated
with hyperlipidemia and inflammation, and become chronic by triggering metabolites in …

Background Diabetes is a predominant driver of coronary artery disease worldwide. This
study aims to unravel the distinct characteristics of oral and gut microbiota in diabetic …

Fecal microbiota transplantation (FMT) is now widely used to treat recurrent Clostridium
difficile infection, but has been less studied as a means to restore microbiome diversity and …

Objectives CD4+ T cells are the key to many immune–inflammatory diseases mediated by
microbial disorders, especially inflammatory bowel disease (IBD). The purpose of this study …

Probiotics are beneficial bacteria that exist within the human gut, and which are also present
in different food products and supplements. They have been investigated for some decades …

Cervical cancer is considered as an important malignancy among women worldwide.
Currently-used treatments of cervical cancer are reported to be cytotoxic for patients …

Atherosclerosis, the underlying cause of cardiovascular diseases such as myocardial
infarction, cerebrovascular accident, and peripheral vascular disease, is the leading cause …

The gut microbiome plays a major role in human health, and gut microbial imbalance or
dysbiosis is associated with disease development. Modulation in the gut microbiome can be …

Gut microbiota (GM) has emerged as an essential and integral factor for maintaining human
health and affecting pathological outcomes. Metagenomics and metabolomics …